-
The company offers test for markers for cancer treatment for both lung and colon cancer to help determine which treatment plans will benefit the patient. The use of genetic testing is getting very specific as well as the tests and expressions. “RGI has determined ranges of ERCC1 expression...
-
Tests to detect cancer of the unknown primary Rosetta Genomics – Today I had the opportunity to speak with and interview Ronen Tamir, Chief Commercialization Officer, at Rosetta to find out how microRNA is helping diagnose and treat cancer. If you have been keeping up with the news of late...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-08-2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Genomics, Biotech, Cancer, Cancer Treatment, Lung Cancer, Rosetta, microRNA, green, microarray, Cancer Tests
-
Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
-
This is a very good point, getting all the data organized into a fashion where it can be used and analyzed. Back a few months ago when I interviewed Patrice Milos, Vice President and Chief Scientific Officer, of Helicos BioSciences I asked the same question, and also if each interpretation would...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, DNA, Genomics, healthcare, microsoft, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
-
Let’s put it another way, it can’t exist without IT. Again it all comes back to running algorithms to obtain desired results. As I have mentioned before, Algorithms is one of the hottest words right now in healthcare as we all make decisions from queried results. A while back I had the opportunity...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-25-2008
Filed under:
Filed under: Medically Related, Technology, Microsoft/Windows News, EMR, personalized medicine, DNA, Genomics, healthcare, microsoft, Medical Records, EHR, Health IT, Biotech, Pharmacogenomics, Helicos, Sequencing
-
Start up companies and biotech engineering is making a big calling as nobody wants or likes the formulas that crippled Wall Street any longer. There’s a lot of work in R and D though where formulas and scientific study are needed to cure diseases, that is for sure. Hopefully all our well educated...
-
I have posted a couple resources here too from past articles, Navigenics has from the beginning focused their DNA and genomic sequencing in the area of physicians versus consumer retail selling methods. This is an important area as some knowledge is certainly better than none and integrating the...
-
The tweezers grab a piece of target DNA and release it on-demand using a controlled series of hydrogen bonding and pH changes. The process of getting the tweezers to grasp and release. This is the first one that can grasp and release, as there have been other developments in this area...
-
The economy is also affecting some of the work and business design of genetic companies. DeCode is is Iceland with offices here in Illinois as well. Biotech companies are starting to feel the crunch as well, even those with breakthrough technology in personalized medicine and part of what...
-
Recently announced is the project to begin at Scripps in San Diego as related news, coupled with the announcement of the new sequencing service that will be able to offer a complete sequence at a wholesale price may have held a bit of inspiration here for Navigenics to enter the full sequencing market...
-
The group has grown in 7 years from five people focused on healthcare worldwide at Microsoft; now there are more than 700. This group is for responsible primarily for the enterprise space (in biopharma and medical devices), so these are the largest customers in the U.S. I have provided a...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-09-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Microsoft/Windows News, personalized medicine, Genomics, healthcare, microsoft, Medical Records, Biotech, R and D, Server 2008, Life Sciences, SharePoint, Windows Presentation Foundation, HPC Server 2008
-
It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-07-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
-
Not only do we see venture capital money here, also some big Pharma names. In a related story, Roche sees diagnostic machines and test kits as crucial to assessing and treating disease in the future and their risk profile has recognition of being one large investor in a growing area of drug research...
-
How hot is genomics today? There are several manufacturers of the machines that will accomplish running our DNA, our complete DNA. I know to the average person this gets a little confusing, but the companies listed here are the companies that manufacture the machines that do the entire work...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-25-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, Genomics, Biotech, Pharmacogenomics, DNA Testing, Helicos, Sequencing, RNA
-
He also did recognize the effect of current budget cuts are having on the progression of R and D, as anyone who applies for and receives grants these days knows the bar has been raised and it is a bit more difficult to secure them, as a result many are looking to investors outside the NIH for funding...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-24-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Genomics, healthcare, Biotech, Grants, Budgets, R and D, NIH, National Institue of Health